PT628. First in class melatonin MT2 receptors agonists for neuropathic pain
Gabriella Gobbi(McGill University), Vinicio Granados‐Soto(Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional), Gilberto Spadoni(University of Urbino), Enza Palazzo(University of Campania "Luigi Vanvitelli"), Debora Angeloni(Scuola Superiore Sant'Anna), Annalida Bedini(University of Urbino), Livio Luongo(University of Campania "Luigi Vanvitelli"), Baptiste Lacoste(University of Ottawa), Sergio Domínguez-López(McGill University Health Centre), Giorgio Tarzia(Université de Montréal), Martha López-Canul(Montreal Neurological Institute and Hospital), Sabatino Maione(University of Campania "Luigi Vanvitelli"), F. Fraschini(University of Milan), Stefano Comai(University of Padua)
Cited by 3
Related Papers
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
|Pharmacological Reviews|2018|386
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
|Nature Neuroscience|2006|373